Cortes JE, Sasaki K, Kim DW, Hughes TP, et al. Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after >/=1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 2024 May 16. doi: 10.1038/s41375-024-02278.
PMID: 38755421